121 related articles for article (PubMed ID: 6590896)
41. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
[No Abstract] [Full Text] [Related]
42. [Combination therapy of vincristine and diltiazem in children with acute lymphocytic leukemia resistant to vincristine during bone marrow relapse].
Yaoi K; Yamamoto S; Tatsumi K; Inoue A; Wakamiya E; Konishi K; Mino M
Rinsho Ketsueki; 1984 Oct; 25(10):1574-80. PubMed ID: 6596445
[No Abstract] [Full Text] [Related]
43. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
44. [EPOCH therapy for relapsed/refractory lymphoid malignancies].
Dobashi N; Usui N; Kobayashi T; Yamazaki H; Asai O; Yano S; Kato A; Watanabe H; Nagamine M; Katori M; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Apr; 39(4):267-72. PubMed ID: 9597893
[TBL] [Abstract][Full Text] [Related]
45. An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood.
Krivit W; Chilcote R; Pyesmany A; Anderson J; Hammond D
Cancer Chemother Pharmacol; 1979; 2(4):267-70. PubMed ID: 287570
[TBL] [Abstract][Full Text] [Related]
46. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
Miller TP; Jones SE; Chester AB; Dorr RT
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
[No Abstract] [Full Text] [Related]
47. [Adjuvant chemotherapy for extranodal non-Hodgkin's lymphoma].
Kuraishi Y; Nagamine D; Usui N; Yamazaki H; Nakamura T; Aiba K; Yokoyama K; Nagata T; Kobayashi A; Ikeda K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2545-9. PubMed ID: 6651308
[TBL] [Abstract][Full Text] [Related]
48. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
Chello PL; Sirotnak FM
Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
[TBL] [Abstract][Full Text] [Related]
49. Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
Gobbi PG; Broglia C; Merli F; Dell'Olio M; Stelitano C; Iannitto E; Federico M; Bertè R; Luisi D; Molica S; Cavalli C; Dezza L; Ascari E
Cancer; 2003 Dec; 98(11):2393-401. PubMed ID: 14635074
[TBL] [Abstract][Full Text] [Related]
50. [Nursing of a patient with stomatitis due to the adverse effect of cancer therapy].
Takahashi S; Kaneko Y; Hori H; Mukita Y
Kangogaku Zasshi; 1985 Feb; 49(2):165-9. PubMed ID: 3856697
[No Abstract] [Full Text] [Related]
51. [Results of phase II clinical trial of vindesine in the treatment of malignant tumors].
Wang J; Zhang H; Sun Y
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):285-8. PubMed ID: 9387323
[TBL] [Abstract][Full Text] [Related]
52. Remission continuation therapy for adult acute lymphoblastic leukemia. Preliminary results with a multidrug treatment protocol.
Rossi G; Verzura P; Marpicati P; Zaniboni A; Ferremi P; Marini G; Marinone G
Chemioterapia; 1984 Jun; 3(3):147-51. PubMed ID: 6597732
[TBL] [Abstract][Full Text] [Related]
53. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
[TBL] [Abstract][Full Text] [Related]
55. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Kumagai K; Takagi T; Sakai C; Wakatsuki S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
[No Abstract] [Full Text] [Related]
56. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
57. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
Al-Ahmad A; Kümmerer K
Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
[TBL] [Abstract][Full Text] [Related]
59. Are platinum-based chemotherapeutic drugs safe for patients with Charcot-Marie-Tooth disease?
Yerushalmi R; Levi I; Wygoda M; Ifergane G; Wirguin I
J Peripher Nerv Syst; 2007 Jun; 12(2):139-41. PubMed ID: 17565539
[No Abstract] [Full Text] [Related]
60. [Preliminary data on treatment with Vindesine in relapses of acute lymphoblastic leukemia].
Jankovic M; Uderzo C; Rossi MR; Locasciulli A; Conter V; Masera G
Haematologica; 1981 Oct; 66(5):710-2. PubMed ID: 6796480
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
